Jubilant Receives Favorable Rulings from the U.S. Patent Office Invalidating Bracco Rubidium-Infusion-System Patents
February 17, 2020 08:00 ET
|
Jubilant Pharma
YARDLEY, Pa., Feb. 17, 2020 (GLOBE NEWSWIRE) -- On February 7, 2020, Jubilant DraxImage Inc., and certain of its affiliates (“Jubilant”) were informed by the U.S. Patent Office that it agreed with...
Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime®
January 27, 2020 16:05 ET
|
Jubilant Pharma
YARDLEY, Pa., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada...
Jubilant Receives Favorable Ruling from the U.S. Courts for RUBY-FILL®
December 11, 2019 16:45 ET
|
Jubilant Pharma
YARDLEY, Pa., Dec. 11, 2019 (GLOBE NEWSWIRE) -- On December 2, 2019, Jubilant DraxImage Inc. and certain of its affiliates (“Jubilant”) received notice of the favorable decision of the U.S....
Curium Announces Revised Pricing for Technescan MAG3TM
September 04, 2019 08:30 ET
|
Curium
St. Louis, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it is implementing a new pricing model for Technescan MAG3. Curium is phasing out its pay per dose sales model, in which...
Telix Pharmaceuticals and Grupo RPH Sign LATAM Manufacturing and Distribution Agreement
July 02, 2019 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and PORTO ALEGRE, Brazil, July 03, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
Telix Pharmaceuticals e Grupo RPH firmam Contrato de Manufatura e Distribuição para a LATAM
July 02, 2019 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Austrália e PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- A Telix Pharmaceuticals Limited (ASX.TLX) ( “Telix”, a “Empresa”), uma empresa biofarmacêutica de fase clínica...
Telix Pharmaceuticals y Grupo RPH firman acuerdo de fabricación y distribución en América Latina
July 02, 2019 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia y PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, la “Compañía”), una compañía biofarmacéutica en fase-clínica,...
RENNOVA HEALTH’S BIG SOUTH FORK MEDICAL CENTER, TN, COMPLETES INSTALLATION OF GE 64 SLICE CT SCANNER
August 27, 2018 09:20 ET
|
Rennova Health, Inc.
WEST PALM BEACH, Fla, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”) a vertically integrated provider of industry-leading diagnostics...
Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research
May 29, 2018 19:00 ET
|
Telix Pharmaceuticals Limited
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
Us Nuclear Corp to Become Miftec’s Exclusive Manufacturer of New Medical Isotope Generators
December 07, 2017 13:25 ET
|
US Nuclear Corp.
LOS ANGELES, CA, Dec. 07, 2017 (GLOBE NEWSWIRE) -- US Nuclear Corp (OTCBB: UCLE) has signed a letter of intent with MIFTEC to become the exclusive contractor to manufacture medical isotope...